Coeptis Therapeutics Holdings Stock Buy Hold or Sell Recommendation
| COEPW Stock | USD 0.02 0.00 0.00% |
Assuming the 90 days horizon and your highly speculative risk level, our recommendation regarding Coeptis Therapeutics Holdings is 'Hold'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Coeptis Therapeutics Holdings given historical horizon and risk tolerance towards Coeptis Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Coeptis Therapeutics Holdings, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Coeptis Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Coeptis Stock please use our How to Invest in Coeptis Therapeutics guide. Note, we conduct extensive research on individual companies such as Coeptis and provide practical buy, sell, or hold advice based on investors' constraints. Coeptis Therapeutics Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Coeptis |
Execute Coeptis Therapeutics Buy or Sell Advice
The Coeptis recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Coeptis Therapeutics Holdings. Macroaxis does not own or have any residual interests in Coeptis Therapeutics Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Coeptis Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Coeptis Therapeutics Trading Alerts and Improvement Suggestions
| Coeptis Therapeutics is way too risky over 90 days horizon | |
| Coeptis Therapeutics has some characteristics of a very speculative penny stock | |
| Coeptis Therapeutics appears to be risky and price may revert if volatility continues | |
| Coeptis Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (37.57 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Coeptis Therapeutics generates negative cash flow from operations |
Coeptis Therapeutics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Coeptis analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Coeptis analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Coeptis Therapeutics Returns Distribution Density
The distribution of Coeptis Therapeutics' historical returns is an attempt to chart the uncertainty of Coeptis Therapeutics' future price movements. The chart of the probability distribution of Coeptis Therapeutics daily returns describes the distribution of returns around its average expected value. We use Coeptis Therapeutics Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Coeptis Therapeutics returns is essential to provide solid investment advice for Coeptis Therapeutics.
| Mean Return | 2.17 | Value At Risk | -30.08 | Potential Upside | 67.70 | Standard Deviation | 24.19 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Coeptis Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Coeptis Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Coeptis Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Coeptis Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Coeptis stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 2.11 | |
β | Beta against Dow Jones | 0.48 | |
σ | Overall volatility | 23.11 | |
Ir | Information ratio | 0.08 |
Coeptis Therapeutics Volatility Alert
Coeptis Therapeutics Holdings is showing large volatility of returns over the selected time horizon. Coeptis Therapeutics Holdings is a penny stock. Although Coeptis Therapeutics may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Coeptis Therapeutics Holdings. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Coeptis instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Coeptis Therapeutics Fundamentals Vs Peers
Comparing Coeptis Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Coeptis Therapeutics' direct or indirect competition across all of the common fundamentals between Coeptis Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Coeptis Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Coeptis Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Coeptis Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Coeptis Therapeutics to competition |
| Fundamentals | Coeptis Therapeutics | Peer Average |
| Return On Equity | -14.5 | -0.31 |
| Return On Asset | -2.46 | -0.14 |
| Number Of Shares Shorted | 9.13 K | 4.71 M |
| EBITDA | (36.35 M) | 3.9 B |
| Net Income | (37.57 M) | 570.98 M |
| Total Debt | 1.71 M | 5.32 B |
| Book Value Per Share | 0.06 X | 1.93 K |
| Cash Flow From Operations | (3.88 M) | 971.22 M |
| Number Of Employees | 4 | 18.84 K |
| Beta | -0.59 | -0.15 |
| Total Asset | 7.92 M | 29.47 B |
| Retained Earnings | (65.74 M) | 9.33 B |
| Working Capital | 2.26 M | 1.48 B |
| Net Asset | 7.92 M |
Coeptis Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Coeptis . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Coeptis Therapeutics Buy or Sell Advice
When is the right time to buy or sell Coeptis Therapeutics Holdings? Buying financial instruments such as Coeptis Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Coeptis Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Data Storage Thematic Idea Now
Data Storage
Companies making data storages or providing data storage services. The Data Storage theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Data Storage Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Coeptis Stock Analysis
When running Coeptis Therapeutics' price analysis, check to measure Coeptis Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coeptis Therapeutics is operating at the current time. Most of Coeptis Therapeutics' value examination focuses on studying past and present price action to predict the probability of Coeptis Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coeptis Therapeutics' price. Additionally, you may evaluate how the addition of Coeptis Therapeutics to your portfolios can decrease your overall portfolio volatility.